Stop harmful marketing of breast-milk substitutes, warn WHO and UNICEF


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ marketing-breastmilk-substitutes-continues-who-unicef
Agencies encourage women to continue to breastfeed during the COVID-19 pandemic

A new report by WHO, UNICEF, and the International Baby Food Action Network (IBFAN) reveals that despite efforts to stop the harmful promotion of breast-milk substitutes, countries are still falling short in protecting parents from misleading information.

The COVID-19 pandemic highlights the need for stronger legislation to protect families from false claims about the safety of breast-milk substitutes or aggressive marketing practices. Breastmilk saves children’s lives as it provides antibodies that give babies a healthy boost and protect them against many childhood illnesses.

WHO and UNICEF encourage women to continue to breastfeed during the COVID-19 pandemic, even if they have confirmed or suspected COVID-19. While researchers continue to test breastmilk from mothers with confirmed or suspected COVID-19, current evidence indicate that it is unlikely that COVID-19 would be transmitted through breastfeeding or by giving breastmilk that has been expressed by a mother who is confirmed or suspected to have COVID-19. The numerous benefits of breastfeeding substantially outweigh the potential risks of illness associated with the virus. It is not safer to give infant formula milk.

Of the 194 countries analysed in the report, 136 have in place some form of legal measure related to the International Code of Marketing of Breast-milk Substitutes and subsequent resolutions adopted by the World Health Assembly (the Code). Attention to the Code is growing, as 44 countries have strengthened their regulations on marketing over the past two years.However, the legal restrictions in most countries do not fully cover marketing that occurs in health facilities. Only 79 countries prohibit the promotion of breast-milk substitutes in health facilities, and only 51 have provisions that prohibit the distribution of free or low-cost supplies within the health care system.

Only 19 countries have prohibited the sponsorship of scientific and health professional association meetings by manufacturers of breast-milk substitutes, which include infant formula, follow-up formula, and growing up milks marketed for use by infants and children up to 36-months old.

“The aggressive marketing of breast-milk substitutes, especially through health professionals that parents trust for nutrition and health advice, is a major barrier to improving newborn and child health worldwide,” says Dr Francesco Branca, Director of WHO’s Department of Nutrition and Food Safety. “Health care systems must act to boost parent’s confidence in breastfeeding without industry influence so that children don’t miss out on its lifesaving benefits.”

WHO and UNICEF recommend that babies be fed nothing but breast milk for their first 6 months, after which they should continue breastfeeding – as well as eating other nutritious and safe foods – until 2 years of age or beyond.

As it is breastfeeding is under threat as health systems stretched thin.Babies who are exclusively breastfed are 14 times less likely to die than babies who are not breastfed. However, today, only 41% of infants 0–6 months old are exclusively breastfed, a rate WHO Member States have committed to increasing to at least 50% by 2025. Inappropriate marketing of breast-milk substitutes continues to undermine efforts to improve breastfeeding rates and the COVID-19 crisis is intensifying the threat.

Health care services aimed at supporting mothers to breastfeed, including counselling and skilled lactation support are strained as a result of the COVID-19 crisis. Infection prevention measures, such as physical distancing make it difficult for community counselling and mother-to-mother support services to continue, leaving an opening for the breast-milk substitute industry to capitalize on the crisis, and diminish confidence in breastfeeding.

“As the COVID-19 pandemic progresses, health workers are being diverted to the response and health systems are overstretched. At such time, breastfeeding can protect the lives of millions of children, but new mothers cannot do it without the support of health providers,” said Dr. Victor Aguayo, UNICEF’s Chief of Nutrition. “We must, more than ever, step up efforts to ensure that every mother and family receive the guidance and support they need from a trained health care worker to breastfeed their children, right from birth, everywhere.”

The Code bans all forms of promotion of breast-milk substitutes, including advertising, gifts to health workers and distribution of free samples. Labels cannot make nutritional and health claims or include images that idealize infant formula. Instead, labels must carry messages about the superiority of breastfeeding over formula and the risks of not breastfeeding.

WHO and UNICEF call on governments to urgently strengthen legislation on the Code during the COVID-19 pandemic. Governments and civil society organizations should also not seek or accept donations of breast-milk substitutes in emergency situations.

“The fear of COVID-19 transmission is eclipsing the importance of breastfeeding – and in too many countries mothers and babies are being separated at birth – making breastfeeding and skin to skin contact difficult if not impossible. All on the basis of no evidence. Meanwhile the baby food industry is exploiting fears of infection, promoting and distributing free formula and misleading advice – claiming that the donations are humanitarian and that they are trustworthy partners,” says Patti Rundall, of IBFAN’s Global Council.

Tags : #WHO #UNICEF #Breastfeeding #Covid-19 #BanBreastmilksubstitutes

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Hormonal Imbalance in Women: Understanding the Causes, Recognising the Symptoms, and Finding the Right TreatmentJuly 28, 2026
Why Regular Health Screening Matters: A Complete Guide for IndiansJuly 28, 2026
Artificial Intelligence in Diagnostic Imaging: Enhancing Radiologist Precision and Reducing Human ErrorJuly 27, 2026
Transitioning from Acute Care to Urgent Care Centers: Optimizing Healthcare Facility InfrastructureJuly 27, 2026
Menopause Symptoms Explained: What Every Indian Woman Should KnowJuly 25, 2026
Sleep Deprivation and Its Hidden Impact on Your Health: What Every Indian Should KnowJuly 25, 2026
Air Pollution and Health Effects: What Every Indian Must KnowJuly 25, 2026
NABH Accreditation Explained: What It Means for Indian Hospitals and PatientsJuly 25, 2026
Hypertension in Young Indians: Causes and Early InterventionJuly 24, 2026
How Stress Damages Your Heart: The Mind-Body ConnectionJuly 24, 2026
Living with Arthritis in India: Pain Management and Lifestyle TipsJuly 23, 2026
Iron Deficiency vs B12 Deficiency: Spotting the Difference in IndiansJuly 23, 2026
The ePlane Company and Apollo Hospitals Join Forces to Bring India's Golden Hour Within ReachJuly 23, 2026
Importance of Women's Health Screening: A Comprehensive Guide to Preventive CareJuly 23, 2026
Can Diabetes Be Reversed? What Indian Patients Need to KnowJuly 23, 2026
Heart Attack vs. Cardiac Arrest: Key Differences Every Indian Should KnowJuly 23, 2026
Hepatitis B and C: Understanding Transmission, Testing, and TreatmentJuly 23, 2026
The Digitization of Care: How Healthtech and Digital Self-Management Tools are Transforming Patient OutcomesJuly 22, 2026
Telemedicine Ethics: Maintaining Patient Privacy and Clinical Quality in Virtual ConsultationsJuly 22, 2026
Diabetes Complications Explained: Causes, Warning Signs, and Prevention for Indian PatientsJuly 22, 2026